Akari Therapeutics PLC AKTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.36quote price arrow down-0.11 (-7.48%)
Volume
20,476
52 week range
1.08 - 5.50
Loading...
  • Open1.58
  • Day High1.59
  • Day Low1.33
  • Prev Close1.47
  • 52 Week High5.50
  • 52 Week High Date08/07/23
  • 52 Week Low1.08
  • 52 Week Low Date04/17/24

Key Stats

  • Market Cap538,804.829
  • Shares Out396,180.00
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change-56.41

KEY STATS

  • Open1.58
  • Day High1.59
  • Day Low1.33
  • Prev Close1.47
  • 52 Week High5.50
  • 52 Week High Date08/07/23
  • 52 Week Low1.08
  • 52 Week Low Date04/17/24
  • Market Cap538,804.829
  • Shares Out396,180.00
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • YTD % Change-56.41

RATIOS/PROFITABILITY

  • EPS (TTM)-5.68
  • P/E (TTM)-0.24
  • Fwd P/E (NTM)-0.36
  • EBITDA (TTM)-16.802M
  • ROE (TTM)-1,281.64%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Akari Therapeutics PLC

 

Profile

MORE
Akari Therapeutics, Plc is a late-stage biotechnology company. The Company is developing advanced therapies for autoimmune and inflammatory diseases. Its lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Its pipeline includes a Phase 3 clinical trial program investigating nomacopan for pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA). It is...
Raymond Prudo-chlebosz M.D.
Non-Executive Chairman of the Board
Rachelle Jacques
President, Chief Executive Officer, Director
Melissa Bradford-klug
Chief Operating Officer
Wendy Dicicco CPA
Interim Chief Financial Officer
Address
22 BOSTON WHARF ROAD, FL 7
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
GOVX
GeoVax Labs Inc
1.59+0.17+11.97%
HEPA
Hepion Pharmaceuticals Inc
1.47-0.05-3.29%
TOVX
Theriva Biologics Inc
0.403-0.015-3.5885%
ENVB
Enveric Biosciences Inc
0.9653+0.0398+4.3004%
CING
Cingulate Inc
0.9805-0.1395-12.4554%